5-HT-moduline controls serotonergic activity: Implication in neuroimmune reciprocal regulation mechanisms

Progress in Neurobiology

Volumn 60, Issue 1, 2000, Pages 1-12

  Grimaldi, B ^a   Fillion, G ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTORECEPTOR; LEUCYLSERYLALANYLLEUCINE; PROTEIN; RECEPTOR SUBTYPE; SEROTONIN 1B RECEPTOR; SEROTONIN RECEPTOR; TETRAPEPTIDE; UNCLASSIFIED DRUG;

CENTRAL NERVOUS SYSTEM; HUMAN; IMMUNOCOMPETENT CELL; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; STRESS; VARICOSIS;

ANIMALS; BRAIN; NEUROIMMUNOMODULATION; NEUROPEPTIDES; OLIGOPEPTIDES; SEROTONIN;

EID: 0033987035     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(98)00074-4     Document Type: Review

References (76)

1. Aghajanian, G. K. (1978) Feedback of central monoaminergic neurons: evidence from single-cell recording studies. In: Assays in Neurochemistry and Neuropharmacology, pp. 1-32. Eds. M. B. Youdim, Y. Lornberg, D. F. Sharman and J. R. Lagnado. Wiley, New York.
2. Agnati L.F., Fuxe K., Zoli M., Ozini I., Toffano G., Ferraguti F. A correlation analysis of the regional distribution of central enkephalin and beta-endorphin immunoreactive terminals and of opiate receptors in adult and old male rats. Evidence for the existence of two main types of communication in the central nervous system: the volume transmission and the wiring transmission. Acta Physiol. Scand. 128(2):1986;201-207.
3. Agnati L.F., Cortelli P., Biagini G., Bjelke B., Fuxe K. Different classes of volume transmission signals exist in the central nervous system and are affected by metabolic signals, temperature gradients and pressure waves. Neuroreport. 6(1):1994;9-12.
4. Agnati L.F., Bjelke B., Fuxe K. Volume versus wiring transmission in the brain: a new theoretical frame for neuropsychopharmacology. Med. Res. Rev. 15(1):1995;33-45.
5. Agnati L.F., Zoli M., Stromberg I., Fuxe K. Intercellular communication in the brain: wiring versus volume transmission. Neuroscience. 69(3):1995;711-726.
6. Audet M.A., Descarries L., Doucet G. Quantified regional and laminar distribution of the serotonin innervation in the anterior half of adult rat cerebral cortex. J. Chem. Neuroanat. 2:1989;29-44.
7. Baumgarten, H. G. and Grozdanovic, Z. (1997) Anatomy of central serotoninergic projection systems. In: Serotoninergic Neurons and 5-HT Receptors in the CNS, Handbook of Experimental Pharmacology, vol. 129, pp. 41-89. Eds. H. G. Baumgarten and M. Göthert. Springer, London.
8. Bizière K., Renoux G. Interactions between the neocortex and lymphocytes. Clin. Neuropharmac. 9(suppl. 4):1986;362-364.
9. 1B receptors in the rat brain. Eur. J. Pharmac. 294:1995;531-540.
10. Bonnet M., Lespinats G., Burtin C. Evidence for serotonin (5-HT) binding sites on murine lymphocytes. Int. J. Immunopharmac. 9:1987;551-556.
11. Bonnin, A., Grimaldi, B., Fillion, M. P. and Fillion, G. (1999) Acute stress induces a differential increase of 5-HT-moduline tissue content in various rat brain areas. Brain Research 825, 152-160.
12. Boranic M., Pericic D., Poljak-Blazi M., Manev H., Sverko V., Gabrilovac J., Radacic M., Pivac N., Miljenovic G. Immune response of stressed rats treated with drugs affecting serotoninergic and adrenergic transmission. Biomed. Pharmacother. 44:1990;381-387.
13. Briley, M. and Chopin, P. (1994) Is anxiety associated with a hyper- or hypo-serotonergic state? In: Studying Brain Disorders, Vol. 1, Depression, anxiety and drug abuse disorders, pp. 197-209. Eds. T. Palomo and T. Archer. Editorial Complutense, Donoso Cortés, Madrid.
14. Briley M., Chopin P., Moret C. Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat. Psychopharmacology. 101:1990;187-189.
15. Chaput Y., De Montigny C. Effects of the 5-hydroxytryptamine-1 receptor antagonist, BMY 7378, on 5-hydroxytryptamine neurotransmission: electrophysiological studies in the rat central nervous system. J. Pharmac. exp. Ther. 246:1988;359-370.
16. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotoninergic system. Brain Res. Rev. 18:1993;1-32.
17. 1B receptors in rat central nervous system (CNS): role of 5-HT-moduline. Submitted.
18. Choquet D., Korn H. Dual effects of serotonin on a voltage-gated conductance in lymphocytes. Proc. natl Acad. Sci. USA. 85:1988;4557-4561.
19. 1B receptors. Proc. natl Acad. Sci. USA. 94:1997;9899-9904.
20. Dantzer, R. and Mormede, P. (1995) Psychoneuroimmunology of stress. In: Stress, the Immune System and Psychiatry, pp. 47-67. Eds. B. E. Leonard and K. Miller.
21. Dantzer, R., Bluthé, R. M., Aubert, A., Goodall, G., Bret-Dibat, J. L., Kent, S., Goujon, E., Layé, S., Parnet, P. and Kelley, K. W. (1996) Cytokine actions on behavior. In: Cytokines in the Nervous System, pp. 117-144. Ed. N. J. Rothwell. R. G. Landes Company.
22. Davis R.B. Discussion of the role of 5-hydroxyindoles in the carcinoid syndrome. Adv. Pharmac. 6:1968;146-149.
23. Descarries, L., Audet, M. A. and Doucet, G. (1990) Morphology of central serotonin neurons. In: The Neuropharmacology of Serotonin, Vol. 600, pp. 81-92. Eds. P. M. Whitaker-Azmitia and S. J. Peroutka. Ann NY Acad Sci.
24. Devoino L., Morozova N., Cheido M. Participation of serotoninergic system in neuroimmunomodulation: intraimmune mechanisms and the pathways providing an inhibitory effect. Int. J. Neurosci. 40:1988;111-128.
25. 1B receptor stimulated inositol phospholipid hydrolysis in CHO cells: synergy with Gq-coupled receptors. Eur. J. Pharmac. 348:1998;279-285.
26. 1B binding sites. Naunyn Schmiedeberg's Arch. Pharmac. 332:1986;1-7.
27. Fillion G., Fillion M.P. Modulation of affinity of postsynaptic serotonin receptors by antidepressant drugs. Nature. 292:1981;349-351.
28. Fuxe K., Agnati L.F., Cintra A., Andersson K., Eneroth P., Harfstrand A., Zoli M., Goldstein M. Studies on central D1 receptors role in volume transmission, neuroendocrine regulation and release of noradrenaline. Adv. exp. Med. Biol. 235:1988;83-119.
29. 3H]hydroxytryptamine in slices of the human neocortex. J. Neurochem. 59:1992;1293-1301.
30. Gemma C., Ghezzi P., De Simoni M.G. Activation of the hypothalamic serotoninergic system by central interleukin-1. Eur. J. Pharmac. 209:1991;139-140.
31. Gemma C., De Luigi A., De Simoni M.G. Permissive role of glucocorticoids on interleukin-1 activation of the hypothalamic serotonergic system. Brain Res. 651:1994;169-173.
32. 1B sites. Arch. Int. Pharmacodyn. Ther. 288:1987;31-42.
33. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmac. Ther. 65:1995;319-395.
34. 1B receptor. Neurosci. Res. 24:1995;97-101.
35. Grimaldi, B., Bonnin, A., Fillion, M. P., Prudhomme, N. and Fillion, G. 5-HT-moduline: a novel endogenous peptide involved in the control of anxiety. Neuroscience, in press.
36. Grimaldi B., Fillion M.P., Bonnin A., Rousselle J.C., Massot O., Fillion G. Immunocytochemical localization of neurons expressing 5-HT-moduline in the mouse brain. Neuropharmacology. 36:1997;1079-1087.
37. Handa R.J., Cross M.K., George M., Gordon B.H., Burgess L.H., Cabrera T.M., Hata N., Campbell D.B., Lorens S.A. Neuroendocrine and neurochemical responses to novelty stress in young and old male F344 rats: effects of D-fenfluramine treatment. Pharmac. Biochem. Behav. 46(1):1993;101-109.
38. 1D receptor subtypes. Trends Pharmac. Sci. 17:1996;103-105.
39. Hellstrand K., Hermodsson S. Role of serotonin in the regulation of human natural killer cell cytotoxicity. J. Immun. 139(3):1987;869-875.
40. 1A-type serotonin receptors. Scand. J. Immun. 32:1990;183-192.
41. Hoyer D., Martin G. 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology. 36(4/5):1997;419-428.
42. 1B receptor antagonist activity. J. Biol. Chem. 17:1997;11657-11662.
43. Jackson J.C., Cross R.J., Walker R.F., Markesbery W.R., Brooks W.H., Roszman T.L. Influence of serotonin on the immune response. Immunology. 54:1985;505-512.
44. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 72:1992;165-229.
45. Jacobs B.L., Fornal C.A. Activity of brain serotonergic neurons in the behaving animal. Pharmac. Rev. 43:1991;563-578.
46. Kawahara H., Yoshida M., Yokoo H., Nishi M., Tanaka M. Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assesses by in vivo microdialysis. Neurosci. Lett. 162:1993;81-84.
47. 2) agonists and antagonists on renin and corticosterone secretion. Neuroendocrinology. 45(4):1987;305-310.
48. Lorens A.S., Hata N., Handa R.J., Van de Kar L.D., Guschwan M., Goral J., Lee M.J., Hamilton M.E., Bethea C.L., Clancy J. Jr. Neurochemical, endocrine and immunological responses to stress in young and old fischer 344 male rats. Neurobiol. Aging. 11:1990;139-150.
49. Mamounas L.A., Molliver M.E. Evidence for dual serotonergic projections to neocortex: Axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA). Exp. Neurol. 102:1988;23-26.
50. 3 receptor, a serotonin-gated ion channel. Science. 254:1991;432-437.
51. Masek K., Kadlecova O., Petrovicky P. The involvement of brain structures in the adjuvant effect of muramyl dipeptide. Brain Res. Bull. 15(5):1985;443-446.
52. Masek K., Petrovicky P., Seifert J. An introduction to the possible role of central nervous system structures in neuroendocrine-immune systems interaction. Int. J. Immunopharmac. 14(3):1992;317-322.
53. 1B/1D receptors. Mol. Pharmac. 50:1996;752-762.
54. 3H]5-HT binding sites and at the 5-HT autoreceptor by propanol. Eur. J. Pharmac. 101:1984;289-293.
55. Middlemiss D.N., Bremer M.E., Smith S.M. A pharmacological analysis of the 5-HT receptor mediating inhibition of 5-HT release in the guinea-pig frontal cortex. Eur. J. Pharmac. 157:1988;101-107.
56. Moukhles H., Bosler O., Bolam J.P., Vallée A., Umbriaco D., Geffard M., Doucet G. Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra. Neuroscience. 76(4):1997;1159-1171.
57. Petrovicky P., Masek K., Seifert J. Brain regulatory system for the immune response: immunopharmacology and morphology. Neuroimmunomodulation. 1(3):1994;165-173.
58. Plantefol, M., Rousselle, J. C., Bernardi, E., Schoof, A. R., Pourrias, B. and Fillion, G. Endoproteolytic activity in mammalian brain membrane cleaves 5-hydroxytryptamine-moduline in two dipeptides. Eur. J. Pharmacol., in press.
59. Rapport M.M., Green A.A., Page I.H. Purification of the substance which is responsible for vasoconstrictor activity of serum. Fed. Proc. 6:1947;184.
60. Renoux G., Bizière K. Asymmetrical involvement of the cerebral neocortex on the response to an immunopotentiator, sodium diethyldithiocarbamate. J. Neurosci. Res. 18(1):1987;230-238.
61. Rosh, P. J. (1995) Future directions in psychoneuroimmunology: psychoelectroneuroimmunology?. In: Stress, the Immune System and Psychiatry, pp. 207-231. Eds. B. E. Leonard and K. Miller. Wiley, Chichester.
62. 1B receptor subtypes. J. Biol. Chem. 271:1996;1-10.
63. 1D receptors expressed in transfected cultured cells. Naunyn-Schmiedeberg's Arch. Pharmac. 358, 279-286.
64. 1B receptors in the rat. Neurosci. Res. 27:1997;277-280.
65. Selbie L.A., Hill S.J. G protein-coupled-receptor cross-talk: the fine tuning of multiple receptor-signalling pathways. TIPS. 19:1998;87-93.
66. Shimizu N., Take S., Hori T., Oomura Y. In vivo measurement of hypothalamic serotonin release by intracerebral microdialysis: significant enhancement by immobilisation stress in rats. Brain Res. Bull. 28:1992;727-734.
67. Silverman D.H.S., Wu H., Karnovsky M.L. Muramyl peptides and serotonin interact at specific binding sites on macrophages and enhance superoxide release. Biochem. biophys. Res. Commun. 131(3):1985;1160-1167.
68. Silverman D.H.S., Krueger J.M., Karnovsky M.L. Specific binding sites for muramyl peptides on murine macrophages. J. Immun. 136:1986;2195-2198.
69. Slauson D.O., Walker C., Kristensen F., Wang Y., de Weck A.L. Mechanisms of serotonin-induced lymphocyte proliferation inhibition. Cell. Immun. 8484:1984;240-252.
70. 1B agonists. Synapse. 1:1987;3-9.
71. Takeuchi, Y. (1988) Distribution of serotonin neurons in the mammalian brain. In: Neuronal Serotonin, pp. 25-56. Eds. N. N. Osborne and M. Hamon. Wiley, Chichester.
72. Törk I. Anatomy of the serotonergic system. Ann. N.Y. Acad. Sci. 600:1990;9-35.
73. Van Loveren H., Den Otter W., Meade R., Terheggen P.M.A.B., Askenase P.W. A role for mast cells and the vasoactive amine serotonin in T cell-dependent immunity to tumors. J. Immun. 134(2):1985;1292-1299.
74. Vialli M., Erspamer V. Cellule enterocromaffini e cellule basigranulose acidofile nei vertebrati. Z. Zellforsch. Mikrosk. Anat. 19:1933;743.
75. Zangen A., Overstreet D.H., Yadid G. High serotonin and 5-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment. J. Neurochem. 69(6):1997;2477-2483.
76. Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Pharmac. Rev. 44:1992;401-458.